[1]
Huang, S.-Y., Chen, T.-Y., Kuo, C.-Y., Chen, Y.-C., Lin, S.-F., Chang, M.-C., Lv, X., Yang, B. and Chang, C.-S. 2019. Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma. Oncology Reviews. 13, 1 (Jan. 2019). DOI:https://doi.org/10.4081/oncol.2019.377.